A citation-based method for searching scientific literature

Josje Altenburg, Casper S de Graaff, Ymkje Stienstra, Jacobus H Sloos, Eric H J van Haren, Ralph J H Koppers, Tjip S van der Werf, Wim G Boersma. JAMA 2013
Times Cited: 309







List of co-cited articles
1030 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
Conroy Wong, Lata Jayaram, Noel Karalus, Tam Eaton, Cecilia Tong, Hans Hockey, David Milne, Wendy Fergusson, Christine Tuffery, Paul Sexton,[...]. Lancet 2012
360
73

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
David J Serisier, Megan L Martin, Michael A McGuckin, Rohan Lourie, Alice C Chen, Barbara Brain, Sally Biga, Sanmarié Schlebusch, Peter Dash, Simon D Bowler. JAMA 2013
265
62

European Respiratory Society guidelines for the management of adult bronchiectasis.
Eva Polverino, Pieter C Goeminne, Melissa J McDonnell, Stefano Aliberti, Sara E Marshall, Michael R Loebinger, Marlene Murris, Rafael Cantón, Antoni Torres, Katerina Dimakou,[...]. Eur Respir J 2017
478
46

The bronchiectasis severity index. An international derivation and validation study.
James D Chalmers, Pieter Goeminne, Stefano Aliberti, Melissa J McDonnell, Sara Lonni, John Davidson, Lucy Poppelwell, Waleed Salih, Alberto Pesci, Lieven J Dupont,[...]. Am J Respir Crit Care Med 2014
508
30

Azithromycin for prevention of exacerbations of COPD.
Richard K Albert, John Connett, William C Bailey, Richard Casaburi, J Allen D Cooper, Gerard J Criner, Jeffrey L Curtis, Mark T Dransfield, Meilan K Han, Stephen C Lazarus,[...]. N Engl J Med 2011
759
28


Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.
Charles S Haworth, Juliet E Foweraker, Peter Wilkinson, Robert F Kenyon, Diana Bilton. Am J Respir Crit Care Med 2014
168
23

British Thoracic Society guideline for non-CF bronchiectasis.
M C Pasteur, D Bilton, A T Hill. Thorax 2010
607
23

Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.
James D Chalmers, Stefano Aliberti, Anna Filonenko, Michal Shteinberg, Pieter C Goeminne, Adam T Hill, Thomas C Fardon, Dusanka Obradovic, Christoph Gerlinger, Giovanni Sotgiu,[...]. Am J Respir Crit Care Med 2018
133
22

British Thoracic Society Guideline for bronchiectasis in adults.
Adam T Hill, Anita L Sullivan, James D Chalmers, Anthony De Soyza, Stuart J Elborn, Andres R Floto, Lizzie Grillo, Kevin Gruffydd-Jones, Alex Harvey, Charles S Haworth,[...]. Thorax 2019
182
22

Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study.
Jennifer K Quint, Elizabeth R C Millett, Miland Joshi, Vidya Navaratnam, Sara L Thomas, John R Hurst, Liam Smeeth, Jeremy S Brown. Eur Respir J 2016
258
21

Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
James D Chalmers, Wim Boersma, Mike Lonergan, Lata Jayaram, Megan L Crichton, Noel Karalus, Steven L Taylor, Megan L Martin, Lucy D Burr, Conroy Wong,[...]. Lancet Respir Med 2019
60
35

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.
Alan F Barker, Anne E O'Donnell, Patrick Flume, Philip J Thompson, Jonathan D Ruzi, Javier de Gracia, Wim G Boersma, Anthony De Soyza, Lixin Shao, Jenny Zhang,[...]. Lancet Respir Med 2014
133
20

Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
Adam T Hill, Charles S Haworth, Stefano Aliberti, Alan Barker, Francesco Blasi, Wim Boersma, James D Chalmers, Anthony De Soyza, Katerina Dimakou, J Stuart Elborn,[...]. Eur Respir J 2017
173
20

Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.
Peter G Gibson, Ian A Yang, John W Upham, Paul N Reynolds, Sandra Hodge, Alan L James, Christine Jenkins, Matthew J Peters, Guy B Marks, Melissa Baraket,[...]. Lancet 2017
340
19

RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
Anthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, J Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L Winthrop, Robert Wilson. Eur Respir J 2018
109
18

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
Timothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L Winthrop, Robert Wilson. Eur Respir J 2018
110
17

A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis.
Simon Finch, Melissa J McDonnell, Hani Abo-Leyah, Stefano Aliberti, James D Chalmers. Ann Am Thorac Soc 2015
199
17

Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.
Timothy R Aksamit, Anne E O'Donnell, Alan Barker, Kenneth N Olivier, Kevin L Winthrop, M Leigh Anne Daniels, Margaret Johnson, Edward Eden, David Griffith, Michael Knowles,[...]. Chest 2017
184
17


Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.
James D Chalmers, Maeve P Smith, Brian J McHugh, Cathy Doherty, John R Govan, Adam T Hill. Am J Respir Crit Care Med 2012
245
16

Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
Sevim Uzun, Remco S Djamin, Jan A J W Kluytmans, Paul G H Mulder, Nils E van't Veer, Anton A M Ermens, Aline J Pelle, Henk C Hoogsteden, Joachim G J V Aerts, Menno M van der Eerden. Lancet Respir Med 2014
157
16

Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.
Patrick A Flume, James D Chalmers, Kenneth N Olivier. Lancet 2018
127
15

The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.
Caroline H H Nicolson, Robert G Stirling, Brigitte M Borg, Brenda M Button, John W Wilson, Anne E Holland. Respir Med 2012
90
15


Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Diana Bilton, Gregory Tino, Alan F Barker, Daniel C Chambers, Anthony De Soyza, Lieven J A Dupont, Conor O'Dochartaigh, Eric H J van Haren, Luis Otero Vidal, Tobias Welte,[...]. Thorax 2014
95
14

Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.
Guy G Brusselle, Christine Vanderstichele, Paul Jordens, René Deman, Hans Slabbynck, Veerle Ringoet, Geert Verleden, Ingel K Demedts, Katia Verhamme, Anja Delporte,[...]. Thorax 2013
297
14

Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.
Miguel Angel Martínez-García, Juan-Jose Soler-Cataluña, Miguel Perpiñá-Tordera, Pilar Román-Sánchez, Joan Soriano. Chest 2007
306
13

A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.
Maeve P Murray, John R W Govan, Catherine J Doherty, A John Simpson, Thomas S Wilkinson, James D Chalmers, Andrew P Greening, Christopher Haslett, Adam T Hill. Am J Respir Crit Care Med 2011
198
13

Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review.
Alessandra Monteiro Brodt, Elizabeth Stovold, Linjie Zhang. Eur Respir J 2014
109
12



Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.
Melissa J McDonnell, Stefano Aliberti, Pieter C Goeminne, Marcos I Restrepo, Simon Finch, Alberto Pesci, Lieven J Dupont, Thomas C Fardon, Robert Wilson, Michael R Loebinger,[...]. Lancet Respir Med 2016
137
12

The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.
David Araújo, Michal Shteinberg, Stefano Aliberti, Pieter C Goeminne, Adam T Hill, Thomas C Fardon, Dusanka Obradovic, Glenda Stone, Marion Trautmann, Angela Davis,[...]. Eur Respir J 2018
107
12

Azithromycin and the risk of cardiovascular death.
Wayne A Ray, Katherine T Murray, Kathi Hall, Patrick G Arbogast, C Michael Stein. N Engl J Med 2012
613
12

Non-cystic fibrosis bronchiectasis.
Pamela J McShane, Edward T Naureckas, Gregory Tino, Mary E Strek. Am J Respir Crit Care Med 2013
228
11

Azithromycin: mechanisms of action and their relevance for clinical applications.
Michael J Parnham, Vesna Erakovic Haber, Evangelos J Giamarellos-Bourboulis, Gianpaolo Perletti, Geert M Verleden, Robin Vos. Pharmacol Ther 2014
280
11

Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.
Amy E Seitz, Kenneth N Olivier, Jennifer Adjemian, Steven M Holland, D Rebecca Prevots. Chest 2012
188
11

Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score.
Miguel Á Martínez-García, Javier de Gracia, Monserrat Vendrell Relat, Rosa-Maria Girón, Luis Máiz Carro, David de la Rosa Carrillo, Casilda Olveira. Eur Respir J 2014
255
11

Clinical phenotypes in adult patients with bronchiectasis.
Stefano Aliberti, Sara Lonni, Simone Dore, Melissa J McDonnell, Pieter C Goeminne, Katerina Dimakou, Thomas C Fardon, Robert Rutherford, Alberto Pesci, Marcos I Restrepo,[...]. Eur Respir J 2016
160
11

Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.
James D Chalmers, Kelly L Moffitt, Guillermo Suarez-Cuartin, Oriol Sibila, Simon Finch, Elizabeth Furrie, Alison Dicker, Karolina Wrobel, J Stuart Elborn, Brian Walker,[...]. Am J Respir Crit Care Med 2017
149
11

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.
Lisa Saiman, Bruce C Marshall, Nicole Mayer-Hamblett, Jane L Burns, Alexandra L Quittner, Debra A Cibene, Sarah Coquillette, Ann Yunker Fieberg, Frank J Accurso, Preston W Campbell. JAMA 2003
692
11

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Lisa Saiman, Michael Anstead, Nicole Mayer-Hamblett, Larry C Lands, Margaret Kloster, Jasna Hocevar-Trnka, Christopher H Goss, Lynn M Rose, Jane L Burns, Bruce C Marshall,[...]. JAMA 2010
233
11

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
Patricia C Valery, Peter S Morris, Catherine A Byrnes, Keith Grimwood, Paul J Torzillo, Paul A Bauert, I Brent Masters, Abbey Diaz, Gabrielle B McCallum, Charmaine Mobberley,[...]. Lancet Respir Med 2013
117
11

Macrolide antibiotics for cystic fibrosis.
Kevin W Southern, Pierre M Barker, Arturo Solis-Moya, Latifa Patel. Cochrane Database Syst Rev 2012
129
11

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.
David J Serisier, Diana Bilton, Anthony De Soyza, Philip J Thompson, John Kolbe, Hugh W Greville, David Cipolla, Paul Bruinenberg, Igor Gonda. Thorax 2013
157
10

Macrolide antibiotics for bronchiectasis.
Carol Kelly, James D Chalmers, Iain Crossingham, Nicola Relph, Lambert M Felix, David J Evans, Stephen J Milan, Sally Spencer. Cochrane Database Syst Rev 2018
48
20

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
Charles S Haworth, Diana Bilton, James D Chalmers, Angela M Davis, Juergen Froehlich, Igor Gonda, Bruce Thompson, Adam Wanner, Anne E O'Donnell. Lancet Respir Med 2019
80
12

Etiology of Non-Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity.
Sara Lonni, James D Chalmers, Pieter C Goeminne, Melissa J McDonnell, Katerina Dimakou, Anthony De Soyza, Eva Polverino, Charlotte Van de Kerkhove, Robert Rutherford, John Davison,[...]. Ann Am Thorac Soc 2015
161
9

Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
Michael M Tunney, Gisli G Einarsson, Lan Wei, Maire Drain, Erich R Klem, Chris Cardwell, Madeleine Ennis, Richard C Boucher, Matthew C Wolfgang, J Stuart Elborn. Am J Respir Crit Care Med 2013
192
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.